(0.26%) 5 145.00 points
(0.15%) 38 499 points
(0.39%) 17 916 points
(-0.62%) $83.33
(1.82%) $1.958
(-0.12%) $2 344.30
(-0.07%) $27.52
(2.90%) $948.80
(-0.01%) $0.935
(-0.06%) $11.02
(-0.23%) $0.799
(1.89%) $93.61
8.01% $ 3.10
Live Chart Being Loaded With Signals
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 5 194.00 |
Średni wolumen | 24 942.00 |
Kapitalizacja rynkowa | 3.63M |
EPS | $0 ( 2024-03-27 ) |
Następna data zysków | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.240 |
ATR14 | $0.0710 (2.29%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-29 | Singh Vanila | Buy | 25 000 | Stock Option (right to buy) |
2024-01-29 | Shah Vinay | Buy | 112 000 | Stock Option (right to buy) |
2024-01-29 | Jambulingam Thani | Buy | 25 000 | Stock Option (right to buy) |
2024-01-29 | Mathias Sheila | Buy | 112 000 | Stock Option (right to buy) |
2024-01-29 | Dubin Michael F | Buy | 25 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
75.05 |
Last 71 transactions |
Buy: 2 396 200 | Sell: 387 701 |
Virpax Pharmaceuticals, Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
XBIO | 0.884 |
TRIP | 0.875 |
LTRPA | 0.868 |
SCWX | 0.852 |
SVAC | 0.851 |
GOODM | 0.845 |
MIND | 0.832 |
YTEN | 0.832 |
PRPO | 0.829 |
NVFY | 0.824 |
10 Najbardziej negatywne korelacje | |
---|---|
LWAC | -0.895 |
SRAC | -0.874 |
AFINO | -0.852 |
NETE | -0.845 |
RAVN | -0.839 |
AMRB | -0.82 |
LMRKN | -0.82 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Virpax Pharmaceuticals, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-12.97 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-12.97 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-18.32 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.67 |
Financial Reports:
No articles found.
Virpax Pharmaceuticals,
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej